Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

Full text

Free full text

Publication Types

Journal Article

Research Support, Non-U.S. Gov't

Review

Clinical Trial

Comparative Study

Controlled Clinical Trial

Research Support, N.I.H., Extramural

Publication Year

From

Quick links

Individual year

2023

2021

2019

2017

2016

2012

2010

2009

2008

2007

2006

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for

""Transmembrane Activator and CAML Interactor Protein""[mesh_terms]

14 Results

Searching titles within these results

Ocrelizumab Treatment Modulates B-Cell Regulating Factors in Multiple Sclerosis.

Samantha Ho, Eva Oswald, Hoi Kiu Wong, Atay Vural, Vuslat Yilmaz, Erdem Tüzün, Recai Türkoğlu, Tobias Straub, Ingrid Meinl, Franziska Thaler, Tania Kümpfel, Edgar Meinl, Simone Mader

Neurology(R) neuroimmunology & neuroinflammation 2023;10(2):e200083

Free Full Text

Abstract

Translational mini-review series on immunodeficiency: molecular defects in common variable immunodeficiency.

C Bacchelli, S Buckridge, A J Thrasher, H B Gaspar

Clinical and experimental immunology 2007;149(3):401-9

Free Full Text

Abstract

Alterations in serotype-specific B cell responses to the 13-valent pneumococcal conjugate vaccine in aging HIV-infected adults.

Jennifer A Ohtola, Noor M Khaskhely, Jessica L Saul-Mcbeth, Anita S Iyer, David J Leggat, Sadik A Khuder, M A Julie Westerink

Vaccine 2016;34(4):451-457

Free Full Text

Abstract

B cell phenotypes in patients with rheumatoid arthritis relapsing after rituximab: expression of B cell-activating factor-binding receptors on B cell subsets.

E Becerra, I De La Torre, M J Leandro, G Cambridge

Clinical and experimental immunology 2017;190(3):372-383

Free Full Text

Abstract

Targeting B-lymphocyte stimulator/B-cell activating factor and a proliferation-inducing ligand in hematologic malignancies.

Latha Shivakumar, Stephen Ansell

Clinical lymphoma & myeloma 2006;7(2):106-8

Full Text

Abstract

Autoimmune manifestations in common variable immunodeficiency.

C Cunningham-Rundles

Journal of clinical immunology 2008;28 Suppl 1(Suppl 1):S42-5

Free Full Text

Abstract

Association of RANK and RANKL gene polymorphism with survival and calcium levels in multiple myeloma.

Piotr Łacina, Aleksandra Butrym, Michał Humiński, Marta Dratwa, Diana Frontkiewicz, Grzegorz Mazur, Katarzyna Bogunia-Kubik

Molecular carcinogenesis 2021;60(2):106-112

Full Text

Abstract

B-cell maturation antigen (BCMA) activation exerts specific proinflammatory effects in normal human keratinocytes and is preferentially expressed in inflammatory skin pathologies.

Vassilia-Ismini Alexaki, Vassiliki Pelekanou, George Notas, Maria Venihaki, Marilena Kampa, Valérie Dessirier, Sanaa Sabour-Alaoui, Efstathios N Stathopoulos, Andreas Tsapis, Elias Castanas

Endocrinology 2012;153(2):739-49

Full Text

Abstract

Raised expression of APRIL in Chinese patients with immune thrombocytopenia and its clinical implications.

Dongsheng Gu, Jing Ge, Weiting Du, Feng Xue, Zhenping Chen, Haifeng Zhao, Zeping Zhou, Jie Xu, Pengxia Liu, Qinjun Zhao, Lei Zhang, Renchi Yang

Autoimmunity 2010;42(8):692-8

Free Full Text

Abstract

The role of TNF-α superfamily members in immunopathogenesis of sepsis.

Dajana F Lendak, Dunja M Mihajlović, Aleksandra S Novakov-Mikić, Igor M Mitić, Jasmina M Boban, Snežana V Brkić

Cytokine 2019;111():125-130

Full Text

Abstract

The rGel/BLyS fusion toxin specifically targets malignant B cells expressing the BLyS receptors BAFF-R, TACI, and BCMA.

Mi-Ae Lyu, Lawrence H Cheung, Walter N Hittelman, John W Marks, Ricardo C T Aguiar, Michael G Rosenblum

Molecular cancer therapeutics 2007;6(2):460-70

Full Text

Abstract

Adipocytes as immune cells: differential expression of TWEAK, BAFF, and APRIL and their receptors (Fn14, BAFF-R, TACI, and BCMA) at different stages of normal and pathological adipose tissue development.

Vassilia-Ismini Alexaki, George Notas, Vassiliki Pelekanou, Marilena Kampa, Maria Valkanou, Panayiotis Theodoropoulos, Efstathios N Stathopoulos, Andreas Tsapis, Elias Castanas

Journal of immunology (Baltimore, Md. : 1950) 2009;183(9):5948-56

Full Text

Abstract

Correlation of APRIL with production of inflammatory cytokines during acute malaria in the Brazilian Amazon.

Raquel A Pinna, Adriana C Dos Santos, Daiana S Perce-da-Silva, Luciene A da Silva, Rodrigo N Rodrigues da Silva, Marcelo R Alves, Fátima Santos, Joseli de Oliveira Ferreira, Josué C Lima-Junior, Déa M Villa-Verde, Paula M De Luca, Carla E Carvalho-Pinto, Dalma M Banic

Immunity, inflammation and disease 2019;6(2):207-220

Free Full Text

Abstract

Polymorphisms in genes of the BAFF/APRIL system may constitute risk factors of B-CLL--a preliminary study on a Polish population.

M Jasek, M Wagner, M Sobczynski, D Wolowiec, K Kuliczkowski, D Woszczyk, M Kielbinski, P Kusnierczyk, I Frydecka, L Karabon

Tissue antigens 2016;86(4):279-84

Full Text

Abstract

Results: 1 – 14 / 14

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Transmembrane Activator and CAML Interactor Protein""[mesh_terms]

Ocrelizumab Treatment Modulates B-Cell Regulating Factors in Multiple Sclerosis.

Translational mini-review series on immunodeficiency: molecular defects in common variable immunodeficiency.

Alterations in serotype-specific B cell responses to the 13-valent pneumococcal conjugate vaccine in aging HIV-infected adults.

B cell phenotypes in patients with rheumatoid arthritis relapsing after rituximab: expression of B cell-activating factor-binding receptors on B cell subsets.

Targeting B-lymphocyte stimulator/B-cell activating factor and a proliferation-inducing ligand in hematologic malignancies.

Autoimmune manifestations in common variable immunodeficiency.

Association of RANK and RANKL gene polymorphism with survival and calcium levels in multiple myeloma.

B-cell maturation antigen (BCMA) activation exerts specific proinflammatory effects in normal human keratinocytes and is preferentially expressed in inflammatory skin pathologies.

Raised expression of APRIL in Chinese patients with immune thrombocytopenia and its clinical implications.

The role of TNF-α superfamily members in immunopathogenesis of sepsis.

The rGel/BLyS fusion toxin specifically targets malignant B cells expressing the BLyS receptors BAFF-R, TACI, and BCMA.

Adipocytes as immune cells: differential expression of TWEAK, BAFF, and APRIL and their receptors (Fn14, BAFF-R, TACI, and BCMA) at different stages of normal and pathological adipose tissue development.

Correlation of APRIL with production of inflammatory cytokines during acute malaria in the Brazilian Amazon.

Polymorphisms in genes of the BAFF/APRIL system may constitute risk factors of B-CLL--a preliminary study on a Polish population.

Results for

""Transmembrane Activator and CAML Interactor Protein""[mesh_terms]